Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunology and world health: key contributions from the global community.

Annals of the New York Academy of Sciences·2013

Same author

Vaccines and future global health needs.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2011

Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009

Same author

Pillars article: antibody production by single cells. 1958. Nature 181: 1419-1420.

Journal of immunology (Baltimore, Md. : 1950)·2009

Same author

Evidence for the clonal abortion theory of B-lymphocyte tolerance. 1975.

Journal of immunology (Baltimore, Md. : 1950)·2007

Same author

One cell-one antibody: prelude and aftermath.

Nature immunology·2007

Search research articles

Related Experiment Video

Updated: May 26, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Vaccines of the future.

¹Department of Pathology, The University of Melbourne, Australia. dewhurst@wehi.edu.au

|December 22, 2011

Summary

Future vaccines target typhoid, meningitis, and more within 10 years. Medium-term goals include malaria, tuberculosis, and HIV/AIDS vaccines, with long-term prospects for autoimmune and cancer vaccines.

Area of Science:

Vaccinology and immunology
Infectious disease prevention
Autoimmune disease therapeutics

Background:

Vaccine development is progressing across near-term, medium-term, and long-term horizons.
Several vaccines for infectious diseases like typhoid and meningitis are nearing realization.
The 'big three' infectious diseases—malaria, tuberculosis, and HIV/AIDS—represent significant medium-term challenges.

Purpose of the Study:

To categorize future vaccine development into distinct timeframes.
To outline specific vaccine candidates and strategies for infectious and autoimmune diseases.
To identify key challenges and future directions in vaccinology.

Main Methods:

Categorization of vaccine development based on projected timelines (<10, 10-19, 20-50 years).

More Related Videos

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Related Experiment Videos

Last Updated: May 26, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Survey of current and emerging vaccine candidates, including conjugate, protein-based, and prime-boost strategies.

Discussion of potential approaches for challenging diseases like malaria, tuberculosis, HIV/AIDS, and autoimmune conditions.

Main Results:

Near-term vaccines include those for typhoid, Neisseria meningitidis serogroup B, shigellosis, Streptococcus pneumoniae, and Group A streptococcus.
Medium-term vaccine development focuses on malaria, tuberculosis (re-engineered BCG, molecular, or prime-boost), and HIV/AIDS (antibody-based and mimotope strategies).
Long-term prospects include vaccines for autoimmune diseases (juvenile diabetes, coeliac disease) and cancer, alongside advancements in combination vaccines, delivery systems, and adjuvants.

Conclusions:

Vaccine development is advancing across multiple fronts, with near-term successes anticipated for several infectious diseases.
Significant progress is expected in the medium term for malaria, tuberculosis, and HIV/AIDS vaccines, though challenges remain.
Long-term research holds promise for tackling autoimmune diseases and cancer through innovative vaccine approaches, supported by improved delivery systems and adjuvants.